Followers | 0 |
Posts | 3,161 |
Boards Moderated | 0 |
Alias Born | 02/25/2019 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RBII Nice action this morning. UP 7.69%
Latest development from $PAOG (link:
)Packaging for #Cannophen THC/CBD Premium Blend Capsules and #BroadSpectrum #CBD Capsules is finalized and ready for print - we are planning to launch both variations at the #HIGHTIMES #CannabisCup Detroit on August 17th-18th.#PAOG #PAOGroup #RisingBioSciences #RBII #GetHIGHEND pic.twitter.com/Chaacfv4ow
— PAO Group $PAOG (@PAOgroup) July 17, 2019
RSB manages a Michigan-based limited-liability corporation, High End Products LLC, which is currently in the process of applying for medical marijuana facility licensing in the state of Michigan through the Department of Licensing And Regulatory Affairs (LARA).
$PAOG debuted some pre-production samples of Cannophen vape cartridge at the Cannabis Cup.
For further details about the HIGH TIMES Cannabis Cup Michigan, please visit: https://www.cannabiscup.com/event/high-times-cannabis-cup-michigan-2019/4
$PAOG plans to announce a release for the 1:1 vape cartridges, which will also feature premium THC distillate and full-spectrum CBD distillate along with organic terpenes, in the near future.
Cannophen™ vape cartridges are currently in pre-production.
$PAOG is my premarket watchlist this morning
GM everyone
$RBII Severely Undervalued #Biotech #Cannabis company that should be trading multiple pennies.
$RBII really gonna rock this weekend. TGIF
CBD only Cannophen opens alot of doors for $RBII
$RBII has some brilliant positioning in this market with these different variants of Cannophen
These shares are still like a steal at this level. $RBII
$RBII Cannophen tackling the $15 Billion anxiety treatment market.
$RBII Cannophen CBD only powering its way to a retail outlet near you!
The third $RBII business unit offers cutting edge behavioral health medical treatment for substance addiction from branches throughout the Midwest.
The second $RBII business unit is a research and development company focusing on oral and topical pharmaceuticals within the strict standards set forward by the pharmaceutical compounding industry and the FDA.
The first $RBII business unit is a physicians practice management company focused on the proper use of cannabis for the treatment of chronic pain, opioid addiction, and terminal patients.
We have a solid pool of liquidity that has accumulated yesterday. Big pop coming
$RBII The Company will be able to deploy a deeper arsenal of marketing and distribution solutions for a CBD only product, including avenues such as online sales platforms.
Adding a CBD only product grants access to a global mainstream market demand that is growing in exponential fashion with no signs of slowing in the near-term future, according to many analysts.
Cannophen is Rising Biosciences flagship product.
CBD only variant of Cannophen Capsules and Vape Cartridges has entered into an initial production run.
Good morning $RBII players
$PAOG they are scouting for land for a Cannophen processing facility in Detroit. Sweet.
Going back to penny town very soon with $PAOG
The High Times Cannabis Cup Cannophen debut was a great tipping point here. $PAOG
CBD only variant is primed for the $5Billion CBD market. $RBII
$RBII Consolidating nicely here.
Latest development from $PAOG
Packaging for #Cannophen THC/CBD Premium Blend Capsules and #BroadSpectrum #CBD Capsules is finalized and ready for print - we are planning to launch both variations at the #HIGHTIMES #CannabisCup Detroit on August 17th-18th.#PAOG #PAOGroup #RisingBioSciences #RBII #GetHIGHEND pic.twitter.com/Chaacfv4ow
— PAO Group $PAOG (@PAOgroup) July 17, 2019
Initial lab tests indicate that Cannophen packs a big whallop with 1 to 1 THC and CBD distillate. $PAOG
a very nice product $PAOG excited when they introduce to the market
Overall CBD market going to $22 Bln by 2022. $RBII
Cannophen has a truly revolutionary delivery system. $RBII
Watching this closely this week I think we could see a strong rally forming.
$RBII is really developing into a strong contender in this space.
CBD only variant of Cannophen Capsules and Vape Cartridges should really leverage open the mainstream market for $RBII
$RBII massive need for addictions treatment in the USA right now. More than ever due to the opiod crisis. Cannophen could be the answer. $RBII
This should be a big week with massive and multiple updates from $RBII
$RBII this opioid crisis is a terrible thing, but its good to see the market rising to meet the challenge. There is some real hope in CBD based treatments.